2024. Roflumilast Cream 0.3% in Patients With Chronic Plaque Psoriasis: Individual Patient PASI and PASI-HD Responses: Pooled DERMIS-1 and DERMIS-2 Phase 3 Trials. SKIN The Journal of Cutaneous Medicine. 8, 2 (Mar. 2024), s355. DOI:https://doi.org/10.25251/skin.8.supp.355.